Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Capital Leases: 2018-2023

Historic Capital Leases for Solid Biosciences (SLDB) over the last 6 years, with Dec 2023 value amounting to $1.2 million.

  • Solid Biosciences' Capital Leases fell 77.46% to $307,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $307,000, marking a year-over-year decrease of 77.46%. This contributed to the annual value of $1.2 million for FY2023, which is 27.54% down from last year.
  • Solid Biosciences' Capital Leases amounted to $1.2 million in FY2023, which was down 27.54% from $1.7 million recorded in FY2022.
  • Over the past 5 years, Solid Biosciences' Capital Leases peaked at $1.7 million during FY2022, and registered a low of $293,000 during FY2021.
  • Its 3-year average for Capital Leases is $1.1 million, with a median of $1.2 million in 2023.
  • Per our database at Business Quant, Solid Biosciences' Capital Leases crashed by 44.19% in 2021 and then surged by 481.23% in 2022.
  • Over the past 5 years, Solid Biosciences' Capital Leases (Yearly) stood at $733,000 in 2019, then decreased by 28.38% to $525,000 in 2020, then slumped by 44.19% to $293,000 in 2021, then skyrocketed by 481.23% to $1.7 million in 2022, then declined by 27.54% to $1.2 million in 2023.